Ayahuasca (Caapi only)

Ayahuasca (Caapi only)

MAOI-containing vine separate from DMT

🚀 Start Tracking

What is it?

Banisteriopsis caapi (ayahuasca vine) contains beta-carboline alkaloids that act as reversible MAO inhibitors. While full ayahuasca combines this with DMT-containing plants, the vine alone has therapeutic potential and is sometimes used for microdosing.

Caapi-only microdosing (0.5-2g dried vine) may offer mild mood elevation, dream enhancement, and potential antidepressant effects without the intense DMT experience. Research is limited but promising.

🚨 Important Warnings

Please read all warnings carefully before use.

⚠️
HIGH

MAOI requires dietary restrictions (tyramine-free diet). Avoid aged cheeses, cured meats, certain fermented foods.

⚠️ Interactions & Combinations

Important information about drug interactions and combinations. Always consult a physician before combining.

SSRIs / Antidepressants

SEVERE

Serotonin Syndrome Risk

MAOI + SSRI can cause dangerous serotonin syndrome. Requires washout period.

💊 Dosage Guidelines

Typical dosage ranges from sub-perceptual microdoses to full psychoactive doses

🔬

Microdose

0.4 g

Sub-perceptual

Threshold

5.0 g

First noticeable effects

🌈

Moderate

15.0 g

Full effects

🚀

Strong

30.0 g

Intense experience

Always start with the lowest dose and gradually increase. Individual sensitivity varies greatly. Never exceed recommended doses without proper research and preparation.

📋 Microdosing Protocols

Recommended protocols and regimens for microdosing this substance.

Caapi Vine Microdose Protocol

Dosage:

0.5-2 g dried vine or 0.4-1 g extract equivalent. Start at lowest dose. Nausea is common at higher doses — reduce if it occurs.

Schedule:

2-3 times per week, non-consecutive days

Caapi-only microdosing uses the vine without DMT-containing admixtures. Effects derive from beta-carboline alkaloids (harmine, harmaline, THH) acting as reversible MAO-A inhibitors with antidepressant-like properties. CRITICAL: dietary and medication restrictions apply at every dose level due to MAO-A inhibition.

Difficulty:

✨ Reported Effects

😊

Mood Enhancement

Beta-carboline alkaloids show antidepressant properties; improved emotional well-being reported at low doses

🧠

Neuroplasticity Support

Harmine promotes BDNF expression and neurogenesis, supporting cognitive resilience

😌

Reduced Anxiety

Calming effect on the nervous system; reduced stress and anxiety reported by regular users

🌙

Dream Enhancement

Increased dream vividness and recall attributed to tetrahydroharmine (THH) content

⚠️ Safety Information

Banisteriopsis caapi contains potent MAO inhibitors — dietary and drug restrictions apply even at microdose levels. Do not combine with SSRIs, SNRIs, MAOIs, tricyclics, stimulants, opioids, or tyramine-rich foods (aged cheese, cured meats, wine) — risk of hypertensive crisis or serotonin syndrome. Contraindicated with many common medications. Consult a healthcare provider before use if taking any prescription drugs.

🔬 Scientific Research

Current research findings and clinical studies.

Harmine and related beta-carboline alkaloids demonstrate antidepressant effects in animal models through multiple mechanisms: MAO-A inhibition, DYRK1A inhibition, BDNF stimulation, and hippocampal neurogenesis promotion.

Institution: Multiple institutions (review)
Year: 2020

Harmine and tetrahydroharmine stimulate proliferation of neural progenitor cells in vitro. This suggests B. caapi alkaloids may promote neurogenesis independently of DMT.

Institution: Beckley Foundation / Sant Pau Hospital
Year: 2017

Randomized, placebo-controlled trial of full ayahuasca for treatment-resistant depression. Significant antidepressant effects observed at day 1, 2, and 7 post-session compared to placebo.

Institution: Federal University of Rio Grande do Norte
Year: 2019

⚖️ Legal Status

Current legal status in various jurisdictions. Always respect local laws.

Jurisdiction Status Details
United States
Legal (unscheduled)
Banisteriopsis caapi vine is not scheduled under the Controlled Substances Act. Legal to possess and sell as a botanical supplement. Only DMT-containing preparations (full ayahuasca) are controlled.
European Union (most countries)
Legal
B. caapi vine is legal in most EU countries and sold as a botanical supplement. Not covered by UN drug conventions. Concentrated extracts may have different status in some jurisdictions.
Brazil
Legal (culturally protected)
Ayahuasca and its plant components are legal for religious and traditional use. Santo Daime and União do Vegetal have full legal recognition for ceremonial use.
France
Controlled
Harmine and harmaline are classified as controlled substances since 2005, making B. caapi vine effectively illegal in France.
Australia
Controlled (Schedule 9)
Harmine and harmaline are Schedule 9 prohibited substances. B. caapi vine is effectively illegal in Australia.
Legal information may change. Always verify current legal status in your jurisdiction.

👤 Key Figures

Notable figures associated with the research and history of this substance.

👤

Richard Evans Schultes

Ethnobotanist

Documented Amazonian medicinal plants including Banisteriopsis caapi.

👤

Luis Eduardo Luna

Anthropologist, researcher

Researched and documented ayahuasca traditions and botanical knowledge.

👤

Dennis McKenna

Ethnopharmacologist

Studied beta-carboline alkaloids and traditional ayahuasca use.

👤

Benny Shanon

Cognitive psychologist

Authored influential analyses of ayahuasca experiences and context.

❓ FAQ

What is "Caapi only" and how does it differ from full ayahuasca?

Traditional ayahuasca is a brew combining Banisteriopsis caapi (MAOI vine) with DMT-containing admixture plants, most commonly Psychotria viridis. "Caapi only" uses the vine alone, without any DMT source. This produces a fundamentally different, non-psychedelic experience focused on the direct pharmacological effects of the beta-carboline alkaloids — primarily harmine, harmaline, and tetrahydroharmine.

Can Caapi vine be used for microdosing?

Some practitioners use low doses of B. caapi (0.5–2g dried vine, or 0.4–1g extract equivalent) for mood support, neuroplasticity, and anxiety reduction. Unlike full ayahuasca, caapi-only microdosing does not produce visions. However, even at low doses, the MAO-A inhibition from beta-carbolines is pharmacologically active, meaning dietary and drug interactions must be taken seriously at any dose level.

Is Caapi vine safe at microdose levels?

Beta-carboline alkaloids inhibit MAO-A even at low doses. This creates meaningful interactions with tyramine-rich foods (aged cheeses, cured meats, fermented products, certain wines) — potentially triggering a hypertensive crisis — and with serotonergic medications including SSRIs, SNRIs, tramadol, and stimulants. These interactions are not dose-dependent in the way that psychedelic effects are. Caapi vine is not pharmacologically mild at any dose and requires the same dietary and medication precautions as clinical MAOI drugs.

Does Caapi vine have antidepressant properties?

Preclinical evidence suggests harmine and related alkaloids may have antidepressant effects through multiple mechanisms: MAO-A inhibition, DYRK1A inhibition, BDNF stimulation, and neurogenesis promotion in animal models. Observational studies of ayahuasca users have documented sustained antidepressant effects, though isolating the caapi vine's contribution from DMT effects is methodologically difficult. No controlled clinical trials have evaluated caapi vine alone for depression.

What is the legal status of Caapi vine?

Banisteriopsis caapi vine is legal in most countries, including the United States and most of Europe, where it is sold as a botanical supplement. It is not scheduled under international drug control conventions. Concentrated extracts may have different regulatory status in some jurisdictions. Always verify current local regulations before purchasing.

Ready to Start?

Start tracking your journey

🚀 Start Tracking

Important Legal Notice

⚠️ Personal Responsibility

You use this application entirely at your own risk and responsibility. MicrodosingDiary is only a tool for recording personal experiences.

🚫 Not a Medical Service

This application IS NOT a medical tool, does not provide medical advice, does not diagnose or treat any conditions. Always consult a qualified physician.

⚖️ Legislation and Laws

Many substances used for microdosing are illegal in many countries. Users are fully responsible for complying with local laws. The application does not support or promote illegal activity.

❌ No Guarantees

We provide no guarantees regarding results, safety or efficacy of microdosing. All information is for informational purposes only.

🔞 Age Restriction

Application is intended only for persons over 18 years of age. By using the application you confirm that you are an adult.

🔒 Data Privacy

Your data is private and encrypted. We never share it with third parties without your consent. Application is for personal use only.

By using this application you accept all the above risks and waive any claims against the application operator.